Commonwealth Equity Services’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-6,984
| Closed | -$649K | – | 3838 |
|
|
2021
Q4 | $649K | Sell |
6,984
-4,696
| -40% | -$309K | ﹤0.01% | 2309 |
|
|
2021
Q3 | $695K | Buy |
11,680
+124
| +1% | +$7.32K | ﹤0.01% | 2222 |
|
|
2021
Q2 | $788K | Sell |
11,556
-100
| -0.9% | -$6.52K | ﹤0.01% | 2099 |
|
|
2021
Q1 | $808K | Sell |
11,656
-315
| -3% | -$24.2K | ﹤0.01% | 1954 |
|
|
2020
Q4 | $919K | Buy |
11,971
+1,283
| +12% | +$96.2K | ﹤0.01% | 1705 |
|
|
2020
Q3 | $799K | Buy |
10,688
+1,470
| +16% | +$98K | ﹤0.01% | 1633 |
|
|
2020
Q2 | $580K | Buy |
9,218
+1,650
| +22% | +$90.8K | ﹤0.01% | 1784 |
|
|
2020
Q1 | $317K | Buy |
7,568
+1,660
| +28% | +$76.1K | ﹤0.01% | 2024 |
|
|
2019
Q4 | $268K | Buy |
5,908
+11
| +0.2% | +$520 | ﹤0.01% | 2404 |
|
|
2019
Q3 | $269K | Sell |
5,897
-796
| -12% | -$44.7K | ﹤0.01% | 2337 |
|
|
2019
Q2 | $392K | Buy |
6,693
+511
| +8% | +$26.4K | ﹤0.01% | 1993 |
|
|
2019
Q1 | $277K | Buy |
6,182
+330
| +6% | +$15.1K | ﹤0.01% | 2223 |
|
|
2018
Q4 | $227K | Hold |
5,852
| – | – | ﹤0.01% | 2235 |
|
|
2018
Q3 | $269K | Buy |
5,852
+496
| +9% | +$20.1K | ﹤0.01% | 2265 |
|
|
2018
Q2 | $234K | Sell |
5,356
-351
| -6% | -$15.1K | ﹤0.01% | 2332 |
|
|
2018
Q1 | $225K | Buy |
+5,707
| New | +$222K | ﹤0.01% | 2308 |
|
|
2017
Q2 | – | Sell |
-2,407
| Closed | -$35K | – | 2576 |
|
|
2017
Q1 | $35K | Sell |
2,407
-525
| -18% | -$7.78K | ﹤0.01% | 2347 |
|
|
2016
Q4 | $42K | Sell |
2,932
-50
| -2% | -$774 | ﹤0.01% | 2250 |
|
|
2016
Q3 | $52K | Sell |
2,982
-250
| -8% | -$4.15K | ﹤0.01% | 2164 |
|
|
2016
Q2 | $55K | Hold |
3,232
| – | – | ﹤0.01% | 2157 |
|
|
2016
Q1 | $64K | Buy |
+3,232
| New | +$51.8K | ﹤0.01% | 2112 |
|
|
2015
Q4 | – | Sell |
-1,232
| Closed | -$24K | – | 2249 |
|
|
2015
Q3 | $24K | Sell |
1,232
-140
| -10% | -$4.75K | ﹤0.01% | 2100 |
|
|
2015
Q2 | $64K | Hold |
1,372
| – | – | ﹤0.01% | 2117 |
|
|
2015
Q1 | $60K | Sell |
1,372
-870
| -39% | -$40.4K | ﹤0.01% | 2106 |
|
|
2014
Q4 | $78K | Buy |
2,242
+73
| +3% | +$2.96K | ﹤0.01% | 1995 |
|
|
2014
Q3 | $91K | Buy |
2,169
+110
| +5% | +$4.91K | ﹤0.01% | 1973 |
|
|
2014
Q2 | $121K | Sell |
2,059
-20
| -1% | -$1.26K | ﹤0.01% | 1916 |
|
|
2014
Q1 | $131K | Buy |
2,079
+250
| +14% | +$16.6K | ﹤0.01% | 1853 |
|
|
2013
Q4 | $107K | Sell |
1,829
-547
| -23% | -$28.6K | ﹤0.01% | 1812 |
|
|
2013
Q3 | $125K | Buy |
2,376
+246
| +12% | +$16.5K | ﹤0.01% | 1740 |
|
|
2013
Q2 | $164K | Buy |
+2,130
| New | +$174K | ﹤0.01% | 1618 |
|
Commonwealth Equity Services's ARNA Position: Q1 2022 in Review
Commonwealth Equity Services sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 6,984 shares — an estimated $649K sold.
Commonwealth Equity Services first reported a position in ARNA in Q2 2013 and held it in 31 quarters. The position peaked at $919K in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Commonwealth Equity Services reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Commonwealth Equity Services sold 6,984 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $649K.
- Commonwealth Equity Services first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 31 quarters.
- Commonwealth Equity Services's Arena Pharmaceuticals Inc position peaked at $919K in Q4 2020.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Commonwealth Equity Services's 13F filing for Q1 2022, filed 4 May 2022.